
Open Innovation in Drug Development
The Express Pharma website reported that the complexities involved in commercializing any new drug has led pharma companies to adopt a more open, collaborative approach for their research and development processes. There are several advantages to introducing open innovation for the drug creation process. Open innovations and collaborations have managed
Comments Off on Open Innovation in Drug Development • Read this story »
More Articles

RPS Summit to Focus on Science and Innovation
The Pharmaceutical Journal website reported that the Royal Pharmaceutical Society’s (RPS) inaugural Winter Summit will take place in London on December 5, 2017. The keynote speech, “Open innovation and drug discovery — the structural genomics consortia story”, will be delivered by
Comments Off on RPS Summit to Focus on Science and Innovation • Read this story »

Pathways to Efficient Drug Development
The Netgadget website reported that collaboration and open innovation will play increasingly important roles in the future by enabling research that would not be possible for companies to undertake individually. Many examples exist, driven in large part by the FDAs Critical Path Initiative and the European
Comments Off on Pathways to Efficient Drug Development • Read this story »